Centene Raises Full-Year 2022 Financial Guidance, Cites Redetermination Delay as Major Reason

During its investor update on June 17, Centene Corp. announced it had increased its adjusted diluted full-year earnings per share (EPS) guidance to between $5.55 and $5.70, up from its April range of between $5.40 and $5.55. The health insurance company also raised its projected annual premium and service revenues by $2 billion to between $134.3 billion and $136.3 billion.

Centene’s executives attributed much of the increase to its better-than-expected performance, particularly in the health insurance exchange market, as well as the delay in the restart of Medicaid eligibility redeterminations.

0

0

0 Comments

0

0

• Health Plan Weekly